Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Meaningful changes in end-of-life care among patients with myeloma.

Odejide OO, Li L, Cronin AM, Murillo A, Richardson PG, Anderson KC, Abel GA.

Haematologica. 2018 May 10. pii: haematol.2018.187609. doi: 10.3324/haematol.2018.187609. [Epub ahead of print]

2.

Cancer drug shortages: Awareness and perspectives from a representative sample of the US population.

Frosch ZAK, Cronin AM, Gagne JJ, Teschke MP, Gray SW, Abel GA.

Cancer. 2018 May 15;124(10):2205-2211. doi: 10.1002/cncr.31246. Epub 2018 Apr 8.

PMID:
29635808
3.

Prevalence of Cognitive Impairment and Association With Survival Among Older Patients With Hematologic Cancers.

Hshieh TT, Jung WF, Grande LJ, Chen J, Stone RM, Soiffer RJ, Driver JA, Abel GA.

JAMA Oncol. 2018 May 1;4(5):686-693. doi: 10.1001/jamaoncol.2017.5674.

PMID:
29494732
4.

Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival.

Khera N, Albelda R, Hahn T, Coronado DS, Odejide OO, Soiffer RJ, Abel GA.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):345-347. doi: 10.1158/1055-9965.EPI-17-1040. Epub 2018 Feb 13.

PMID:
29440120
5.

What happens to patient experience when you want to see a doctor and you get to speak to a nurse? Observational study using data from the English General Practice Patient Survey.

Paddison CAM, Abel GA, Burt J, Campbell JL, Elliott MN, Lattimer V, Roland M.

BMJ Open. 2018 Feb 3;8(2):e018690. doi: 10.1136/bmjopen-2017-018690.

6.

The nature and frequency of abdominal symptoms in cancer patients and their associations with time to help-seeking: evidence from a national audit of cancer diagnosis.

Koo MM, von Wagner C, Abel GA, McPhail S, Hamilton W, Rubin GP, Lyratzopoulos G.

J Public Health (Oxf). 2018 Jan 27. doi: 10.1093/pubmed/fdx188. [Epub ahead of print]

PMID:
29385513
7.

What Does a Cancer Diagnosis Mean? Public Expectations in a Shifting Therapeutic Environment.

Frosch ZAK, Gagne JJ, Gray SW, Abel GA.

J Oncol Pract. 2018 Mar;14(3):139-140. doi: 10.1200/JOP.17.00009. Epub 2018 Jan 30. No abstract available.

PMID:
29381410
8.

Risk and timing of cardiovascular death among patients with myelodysplastic syndromes.

Brunner AM, Blonquist TM, Hobbs GS, Amrein PC, Neuberg DS, Steensma DP, Abel GA, Fathi AT.

Blood Adv. 2017 Oct 18;1(23):2032-2040. doi: 10.1182/bloodadvances.2017010165. eCollection 2017 Oct 24.

9.

Management of older adults with myelodysplastic syndromes (MDS).

Luskin MR, Abel GA.

J Geriatr Oncol. 2018 Jul;9(4):302-307. doi: 10.1016/j.jgo.2017.12.002. Epub 2017 Dec 29. Review.

PMID:
29290596
10.

Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit.

Swann R, McPhail S, Witt J, Shand B, Abel GA, Hiom S, Rashbass J, Lyratzopoulos G, Rubin G; National Cancer Diagnosis Audit Steering Group.

Br J Gen Pract. 2018 Jan;68(666):e63-e72. doi: 10.3399/bjgp17X694169. Epub 2017 Dec 18.

11.

Associations between diagnostic activity and measures of patient experience in primary care: a cross-sectional ecological study of English general practices.

Lyratzopoulos G, Mendonca SC, Gildea C, McPhail S, Peake MD, Rubin G, Singh H, Hamilton W, Walter FM, Roland M, Abel GA.

Br J Gen Pract. 2018 Jan;68(666):e9-e17. doi: 10.3399/bjgp17X694097. Epub 2017 Dec 18.

12.

Variation in 'fast-track' referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites.

Zhou Y, Mendonca SC, Abel GA, Hamilton W, Walter FM, Johnson S, Shelton J, Elliss-Brookes L, McPhail S, Lyratzopoulos G.

Br J Cancer. 2018 Jan;118(1):24-31. doi: 10.1038/bjc.2017.381. Epub 2017 Nov 28.

13.

Missing data and chance variation in public reporting of cancer stage at diagnosis: Cross-sectional analysis of population-based data in England.

Barclay ME, Lyratzopoulos G, Greenberg DC, Abel GA.

Cancer Epidemiol. 2018 Feb;52:28-42. doi: 10.1016/j.canep.2017.11.005. Epub 2017 Nov 23.

14.

Frailty and the management of hematologic malignancies.

Abel GA, Klepin HD.

Blood. 2018 Feb 1;131(5):515-524. doi: 10.1182/blood-2017-09-746420. Epub 2017 Nov 15. Review.

PMID:
29141942
15.

Associations Between Sexual Orientation and Overall and Site-Specific Diagnosis of Cancer: Evidence From Two National Patient Surveys in England.

Saunders CL, Meads C, Abel GA, Lyratzopoulos G.

J Clin Oncol. 2017 Nov 10;35(32):3654-3661. doi: 10.1200/JCO.2017.72.5465. Epub 2017 Sep 25.

16.

Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.

Zeidan AM, Long JB, Wang R, Hu X, Yu JB, Huntington SF, Abel GA, Mougalian SS, Podoltsev NA, Gore SD, Gross CP, Ma X, Davidoff AJ.

PLoS One. 2017 Sep 13;12(9):e0184747. doi: 10.1371/journal.pone.0184747. eCollection 2017.

17.

Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis.

Koo MM, von Wagner C, Abel GA, McPhail S, Rubin GP, Lyratzopoulos G.

Cancer Epidemiol. 2017 Jun;48:140-146. doi: 10.1016/j.canep.2017.04.010. Epub 2017 May 23.

18.

Why are patients with blood cancers more likely to die without hospice?

Odejide OO, Cronin AM, Earle CC, Tulsky JA, Abel GA.

Cancer. 2017 Sep 1;123(17):3377-3384. doi: 10.1002/cncr.30735. Epub 2017 May 22.

PMID:
28542833
19.

Aptitude; Mother's Day; Winter Beach.

Abel GA.

J Clin Oncol. 2017 Aug 20;35(24):2848. doi: 10.1200/JCO.2017.73.4384. Epub 2017 May 24. No abstract available.

PMID:
28537811
20.

Quitting patient care and career break intentions among general practitioners in South West England: findings of a census survey of general practitioners.

Fletcher E, Abel GA, Anderson R, Richards SH, Salisbury C, Dean SG, Sansom A, Warren FC, Campbell JL.

BMJ Open. 2017 Apr 11;7(4):e015853. doi: 10.1136/bmjopen-2017-015853.

21.

Emergency diagnosis of cancer and previous general practice consultations: insights from linked patient survey data.

Abel GA, Mendonca SC, McPhail S, Zhou Y, Elliss-Brookes L, Lyratzopoulos G.

Br J Gen Pract. 2017 Jun;67(659):e377-e387. doi: 10.3399/bjgp17X690869. Epub 2017 Apr 24.

22.

Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study.

Walter FM, Mills K, Mendonça SC, Abel GA, Basu B, Carroll N, Ballard S, Lancaster J, Hamilton W, Rubin GP, Emery JD.

Lancet Gastroenterol Hepatol. 2016 Dec;1(4):298-306. doi: 10.1016/S2468-1253(16)30079-6. Epub 2016 Oct 4.

23.

Self-reported sleep disturbance and survival in myelodysplastic syndromes.

Luskin MR, Cronin AM, Owens RL, DeAngelo DJ, Stone RM, Wadleigh M, Steensma DP, Abel GA.

Br J Haematol. 2017 May;177(4):562-566. doi: 10.1111/bjh.14573. Epub 2017 Mar 8.

PMID:
28272741
24.

Low-molecular weight heparin versus vitamin K antagonists for the treatment of cancer-associated thrombosis: A cost-effectiveness analysis.

Connell NT, Abel GA, Connors JM.

Thromb Res. 2017 Feb;150:53-58. doi: 10.1016/j.thromres.2016.12.017. Epub 2016 Dec 22.

PMID:
28039844
25.

Identifying people at higher risk of melanoma across the U.K.: a primary-care-based electronic survey.

Usher-Smith JA, Kassianos AP, Emery JD, Abel GA, Teoh Z, Hall S, Neal RD, Murchie P, Walter FM.

Br J Dermatol. 2017 Apr;176(4):939-948. doi: 10.1111/bjd.15181. Epub 2016 Dec 23.

PMID:
28009060
26.
27.

Diagnosis of cancer as an emergency: a critical review of current evidence.

Zhou Y, Abel GA, Hamilton W, Pritchard-Jones K, Gross CP, Walter FM, Renzi C, Johnson S, McPhail S, Elliss-Brookes L, Lyratzopoulos G.

Nat Rev Clin Oncol. 2017 Jan;14(1):45-56. doi: 10.1038/nrclinonc.2016.155. Epub 2016 Oct 11. Review.

PMID:
27725680
28.

High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.

Zhou Z, Rademaker AW, Gordon LI, LaCasce AS, Crosby-Thompson A, Vanderplas A, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson MM, Zelenetz AD, Niland J, Friedberg JW, Winter JN.

J Natl Compr Canc Netw. 2016 Oct;14(10):1274-1281.

29.

Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes.

Zeidan AM, Davidoff AJ, Long JB, Hu X, Wang R, Ma X, Gross CP, Abel GA, Huntington SF, Podoltsev NA, Hajime U, Prebet T, Gore SD.

Br J Haematol. 2016 Dec;175(5):829-840. doi: 10.1111/bjh.14305. Epub 2016 Sep 21.

PMID:
27650975
30.

Assessing Quality of Care for the Myelodysplastic Syndromes.

Frosch ZA, Abel GA.

Curr Hematol Malig Rep. 2016 Dec;11(6):402-407. doi: 10.1007/s11899-016-0343-0. Review.

PMID:
27562670
31.

Modest improvement in survival of patients with refractory anemia with excess blasts in the hypomethylating agents era in the United States.

Zeidan AM, Wang R, Gross CP, Gore SD, Huntington SF, Prebet T, Abel GA, Davidoff AJ, Ma X.

Leuk Lymphoma. 2017 Apr;58(4):982-985. doi: 10.1080/10428194.2016.1214954. Epub 2016 Aug 25. No abstract available.

PMID:
27558206
32.

Relationship between physician and patient assessment of performance status and survival in a large cohort of patients with haematologic malignancies.

Liu MA, Hshieh T, Condron N, Wadleigh M, Abel GA, Driver JA.

Br J Cancer. 2016 Sep 27;115(7):858-61. doi: 10.1038/bjc.2016.260. Epub 2016 Aug 23.

33.

Small Step for Geriatric Oncology That Could Have Been a Giant Leap.

Nipp RD, Abel GA.

J Clin Oncol. 2016 Nov 20;34(33):4048-4049. doi: 10.1200/JCO.2016.69.0446. Epub 2016 Oct 31. No abstract available.

PMID:
27551124
34.

Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health.

Schnipper LE, Abel GA.

JAMA Oncol. 2016 Nov 1;2(11):1397-1398. doi: 10.1001/jamaoncol.2016.2463. No abstract available.

PMID:
27532895
35.

Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: results from a prospective cohort study.

Walter FM, Emery JD, Mendonca S, Hall N, Morris HC, Mills K, Dobson C, Bankhead C, Johnson M, Abel GA, Rutter MD, Hamilton W, Rubin GP.

Br J Cancer. 2016 Aug 23;115(5):533-41. doi: 10.1038/bjc.2016.221. Epub 2016 Aug 4.

36.

Barriers to Quality End-of-Life Care for Patients With Blood Cancers.

Odejide OO, Cronin AM, Condron NB, Fletcher SA, Earle CC, Tulsky JA, Abel GA.

J Clin Oncol. 2016 Sep 10;34(26):3126-32. doi: 10.1200/JCO.2016.67.8177. Epub 2016 Jul 11.

PMID:
27400944
37.

Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis.

El-Jawahri A, Keenan T, Abel GA, Steensma DP, LeBlanc TW, Chen YB, Hobbs G, Traeger L, Fathi AT, DeAngelo DJ, Wadleigh M, Ballen KK, Amrein PC, Stone RM, Temel JS.

Lancet Haematol. 2016 Jun;3(6):e276-83. doi: 10.1016/S2352-3026(16)30024-2. Epub 2016 May 18.

PMID:
27264037
38.

Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes.

Abel GA, Buckstein R.

Am Soc Clin Oncol Educ Book. 2016;35:e337-44. doi: 10.14694/EDBK_158639. Review.

39.

Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation.

Abel GA, Albelda R, Khera N, Hahn T, Salas Coronado DY, Odejide OO, Bona K, Tucker-Seeley R, Soiffer R.

Biol Blood Marrow Transplant. 2016 Aug;22(8):1504-1510. doi: 10.1016/j.bbmt.2016.05.008. Epub 2016 May 13.

40.

Novel Data Sharing Between a Comprehensive Cancer Center and a Private Payer to Better Understand Care at the End of Life.

Stuver SO, McNiff K, Fraile B, Odejide O, Abel GA, Dodek A, Jacobson JO.

J Pain Symptom Manage. 2016 Aug;52(2):161-9. doi: 10.1016/j.jpainsymman.2016.02.004. Epub 2016 Mar 24.

PMID:
27033156
41.

Impact of socioeconomic deprivation on screening for cardiovascular disease risk in a primary prevention population: a cross-sectional study.

Lang SJ, Abel GA, Mant J, Mullis R.

BMJ Open. 2016 Mar 21;6(3):e009984. doi: 10.1136/bmjopen-2015-009984.

42.

Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS?

El-Jawahri A, Kim HT, Steensma DP, Cronin AM, Stone RM, Watts CD, Chen YB, Cutler CS, Soiffer RJ, Abel GA.

Bone Marrow Transplant. 2016 Aug;51(8):1121-6. doi: 10.1038/bmt.2016.40. Epub 2016 Mar 21.

PMID:
26999469
43.

Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS).

Abel GA, Efficace F, Buckstein RJ, Tinsley S, Jurcic JG, Martins Y, Steensma DP, Watts CD, Raza A, Lee SJ, List AF, Klaassen RJ.

Haematologica. 2016 Jun;101(6):781-8. doi: 10.3324/haematol.2015.140335. Epub 2016 Mar 4.

44.

Pre-referral GP consultations in patients subsequently diagnosed with rarer cancers: a study of patient-reported data.

Mendonca SC, Abel GA, Lyratzopoulos G.

Br J Gen Pract. 2016 Mar;66(644):e171-81. doi: 10.3399/bjgp16X683977.

45.

Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.

Fletcher SA, Cronin AM, Zeidan AM, Odejide OO, Gore SD, Davidoff AJ, Steensma DP, Abel GA.

Cancer. 2016 Apr 15;122(8):1209-15. doi: 10.1002/cncr.29913. Epub 2016 Feb 23.

46.

Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromes.

Abel GA, Cronin AM, Odejide OO, Uno H, Stone RM, Steensma DP.

Br J Haematol. 2016 Jun;173(5):713-21. doi: 10.1111/bjh.13987. Epub 2016 Feb 23.

PMID:
26913376
47.

Post-sampling mortality and non-response patterns in the English Cancer Patient Experience Survey: Implications for epidemiological studies based on surveys of cancer patients.

Abel GA, Saunders CL, Lyratzopoulos G.

Cancer Epidemiol. 2016 Apr;41:34-41. doi: 10.1016/j.canep.2015.12.010. Epub 2016 Jan 18.

48.

Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists.

Odejide OO, Cronin AM, Condron N, Earle CC, Wolfe J, Abel GA.

JAMA Intern Med. 2016 Feb;176(2):263-5. doi: 10.1001/jamainternmed.2015.6599. No abstract available.

PMID:
26720644
49.
50.

Beyond the ecological fallacy: potential problems when studying healthcare organisations.

Saunders CL, Elliott MN, Lyratzopoulos G, Abel GA.

J R Soc Med. 2016 Mar;109(3):92-7. doi: 10.1177/0141076815610574. Epub 2015 Oct 8. No abstract available.

PMID:
26450917

Supplemental Content

Support Center